Anavex Life Sciences AVXL
NASDAQ AVXL
$1.82 -0.07 (-3.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Depreciation & Amortization (CF) (2010 - 2016)

Updated

Anavex Life Sciences (AVXL) posted Depreciation & Amortization (CF) of $506.00 for fiscal Q4 2016 (quarter ended Sep 30, 2016), up 103.2% from $249.00 a year earlier and up 103.2% from the prior quarter.

Analysis

Anavex Life Sciences (AVXL) Depreciation & Amortization (CF) (2010 - 2016) Analysis & Trends

For FY2016 (ended Sep 30, 2016), Anavex Life Sciences' Depreciation & Amortization (CF) came in at $1,252, up 25.8% from FY2015.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive fiscal years, though with a five-year compound annual growth rate of -5.5% (FY2011 to FY2016).
  • In prior fiscal years, Anavex Life Sciences' Depreciation & Amortization (CF) was $995.00 in FY2015 (+29.6%), $768.00 in FY2014 (+33.3%), $576.00 in FY2013 (-69.0%) and $1,858 in FY2012 (+12.1%).
  • The fiscal Q4 2016 figure stands as the highest quarterly Depreciation & Amortization (CF) in data going back to fiscal Q4 2010.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 27.7%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was fiscal Q4 2016, with growth of 103.2%; the weakest was fiscal Q2 2013, with a decline of 76.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $249.00 (Q3 2016), $248.00 (Q2 2016) and $249.00 (Q1 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Anavex Life Sciences 168.71 Mn -311.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 506.00
Jun 30, 2016 249.00
Mar 31, 2016 248.00
Dec 31, 2015 249.00
Sep 30, 2015 249.00
Jun 30, 2015 248.00
Mar 31, 2015 249.00
Dec 31, 2014 249.00
Sep 30, 2014 192.00
Jun 30, 2014 192.00
Mar 31, 2014 192.00
Dec 31, 2013 192.00
Mar 31, 2013 111.00
Dec 31, 2012 465.00
Sep 30, 2012 464.00
Jun 30, 2012 465.00
Mar 31, 2012 465.00
Dec 31, 2011 464.00
Sep 30, 2011 382.00
Jun 30, 2011 377.00
API Access

Anavex Life Sciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AVXL&period=max&api_key=YOUR_API_KEY